Vteu phase 1 zika virus vaccine trials in US and puerto rico

Ended Awarded Last action

Contract number
HHSN27200014
Awardee
Awarding agency
Obligated
$2,779,750

Award facts

Opportunity
Contract value 100% obligated
$2,779,749.96 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
St. Louis, MO 63108, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00007 $0
Supplemental Agreement for work within scope P00006 $0
Supplemental Agreement for work within scope P00005 $0
Supplemental Agreement for work within scope P00004 · The purpose of this modification is to deobligate FY17 funds from line 2 base (task area b, task area c) change order and update various articles and clauses. -$139,930
Funding Only Action P00003 · The purpose of this modification is to obligate $113,642.00 as line 3 base (task area b, task area c) cost overrun and update various articles and clauses. $113,642
Other Administrative Action P00002 · The purpose of this modification is to extend the period of performance, update the COR, and update various articles and clauses. $0
Change Order 1 $1,458,695
Original award $1,347,343

About this award

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. government, awarded a $2,779,749.96 delivery order contract to Saint Louis University, a private Jesuit research university, for Phase 1 Zika virus vaccine trials in the U.S. and Puerto Rico. This contract is part of the Vaccine and Treatment Evaluation Units (VTEU) program, which focuses on the development and evaluation of vaccines and treatments for infectious diseases. The contract does not have a set-aside designation, indicating it was competed on an open and full and open basis. Saint Louis University is an experienced federal contractor and grant recipient, having secured numerous awards from agencies such as the National Institutes of Health, the National Science Foundation, and the Department of Defense for various research and educational initiatives.

Quick answers

Who was awarded contract HHSN27200014?

HHSN27200014 was awarded to Saint Louis University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 12, 2016.

How much is contract HHSN27200014 worth?

The government has obligated $2,779,750 on HHSN27200014.

Is contract HHSN27200014 an order under another contract?

Yes. HHSN27200014 is a delivery order under HHSN272201300021I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).

Was contract HHSN27200014 competed?

The extent of competition for HHSN27200014 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award